| 000 | 01797 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517105519.0 | ||
| 264 | 0 | _c20170901 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1476-5551 | ||
| 024 | 7 |
_a10.1038/leu.2016.182 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDonato, E | |
| 245 | 0 | 0 |
_aCompensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors. _h[electronic resource] |
| 260 |
_bLeukemia _c02 2017 |
||
| 300 |
_a479-490 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAzepines _xpharmacology |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Cycle Proteins |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aChromatin _xgenetics |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase 9 _xmetabolism |
| 650 | 0 | 4 |
_aE2F Transcription Factors _xmetabolism |
| 650 | 0 | 4 | _aEnhancer Elements, Genetic |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xgenetics |
| 650 | 0 | 4 |
_aNuclear Proteins _xmetabolism |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-myc _xgenetics |
| 650 | 0 | 4 |
_aRNA Polymerase II _xmetabolism |
| 650 | 0 | 4 |
_aTranscription Factors _xmetabolism |
| 650 | 0 | 4 | _aTranscription, Genetic |
| 650 | 0 | 4 |
_aTriazoles _xpharmacology |
| 700 | 1 | _aCroci, O | |
| 700 | 1 | _aSabò, A | |
| 700 | 1 | _aMuller, H | |
| 700 | 1 | _aMorelli, M J | |
| 700 | 1 | _aPelizzola, M | |
| 700 | 1 | _aCampaner, S | |
| 773 | 0 |
_tLeukemia _gvol. 31 _gno. 2 _gp. 479-490 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/leu.2016.182 _zAvailable from publisher's website |
| 999 |
_c26251610 _d26251610 |
||